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Silent Ureteral Stones: Impact on Kidney
Function—Can Treatment of Silent
Ureteral Stones Preserve Kidney Function?
Giovanni S. Marchini, Fabio C. Vicentini, Eduardo Mazzucchi, Arthur Brito,
Gustavo Ebaid, and Miguel Srougi
OBJECTIVE To report our experience with silent ureteral stones and expose their true influence on renal
function.
METHODS We analyzed 506 patients who had undergone ureterolithotripsy from January 2005 to May 2010.
Silent ureteral stones were calculi found in the absence of any specific or subjective ureteral
stone-related symptoms. Of the 506 patients, 27 (5.3%) met these criteria (global cohort). All
patients were assessed postoperatively with dimercaptosuccinic acid scintigraphy (DMSA). A
difference in relative kidney function of 10% was considered abnormal. Pre- and postoperative
comparative DMSA analyses were electively obtained for 9 patients (kidney function cohort). A
t test was used to assess the numeric variables, and the chi-square test or Fisher’s exact test was
used for categorical variables. Two-tailed P  .05 was considered statistically significant.
RESULTS Stones were diagnosed by radiologic abdominal evaluation for nonurologic diseases in 40% and
after previous nephrolithiasis treatment in 33%. The primary therapy was ureterolithotripsy in
88%. The mean follow-up time was 23 months. The overall ureteral stone-free rate after 1 and
2 procedures was 96% and 100%, respectively. In the global cohort, the mean pre- and
postoperative serum creatinine levels were similar (P  .39), and the mean postoperative
function on DMSA was 31%. In the kidney function cohort, no difference was found between
the pre- and postoperative DMSA findings (22% 12.1% vs 20% 11.8%; P .83) and serum
creatinine (0.8  0.13 mg/dL vs 1.0  0.21 mg/dL; P  .45).
CONCLUSION Silent ureteral stones are associated with decreased kidney function present at the diagnosis.
Hydronephrosis tends to diminish after stone removal, and kidney function remains
unaltered. UROLOGY 79: 304–309, 2012. © 2012 Elsevier Inc.
The prevalence of nephrolithiasis is increasingworldwide, reaching 5.2% in North America and10.1% in Italy.1-3 The widespread use of com-
puted tomography and ultrasonography have resulted in a
greater detection rate of asymptomatic stones and, in
part, might explain the trend.1 Clinically, kidney or
ureteral stones range in severity from asymptomatic to
presenting with complete renal failure. North American
dialysis centers reported an incidence of nephrolithiasis-
related end-stage renal disease of 4.7%.4 Therefore, it is
not only the alarming incidence of urinary stone disease,
but also the associated burden that makes this 1 of the
most concerning conditions in public health.
The situation becomes even more distressing when man-
aging asymptomatic stones. Studies of the natural history of
stones have revealed that only 20% of patients yearly actu-
ally become symptomatic from a new stone, and one half of
those require surgical intervention at some point.5-7 The
guidelines are well established for the treatment of symp-
tomatic urolithiasis, and many investigators have exten-
sively studied the management of silent kidney stones.
However, the same is not true for silent ureterolithiasis. To
date, only 1 report has addressed silent ureteral stones,
emphasizing the diagnostic workup and surgical manage-
ment.8 However, no conclusions were made regarding the
calculi or the effect of treatment on renal function. The
purpose of the present study is to report our 5-year experi-
ence managing silent ureteral stones and to expose their
true influence on renal function.
MATERIAL AND METHODS
Selection Criteria and Case Definition
We analyzed the data from patients who had undergone ureteral
stone removal from January 2005 to May 2010. We included all
patients referred to our urology emergency division or elective
office setting for the evaluation of ureteral calculi. Silent ureteral
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stone disease was defined as a ureteral stone found in a patient
without any type of specific or subjective ureteral stone-related
symptoms, including acute or chronic flank pain, nonspecific ab-
dominal pain, dysuria, gross hematuria, anuria, or urinary tract
infection. The presence of hydronephrosis or decreased renal func-
tion at diagnosis and the development of pain or infection were
considered the main indications for interventional treatment. The
internal review board approved the present study.
Patient and Data Collection
In the 5-year period analyzed, 506 patients underwent ureter-
olithotripsy for ureteral stone removal at our institution. Data were
collected retrospectively and included the following: patient age,
sex, body mass index, comorbidities, diagnostic workup, stone
characteristics, intensity of hydronephrosis, intervention type, op-
erative findings, complications, stone-free rate, and effect on renal
function. Stone-free status was defined as the absence of any new
calculi-related symptoms and complete absence of ureteral stones
on ultrasonography or computed tomography performed 90 days
after surgical treatment. When double-J catheter implantation was
required, the surgeon evaluated the local ureteral conditions, and
the stenting time was established. Ultrasonography or computed
tomography and dimercaptosuccinic acid scintigraphy (DMSA)
were performed routinely in all cases 3 months postoperatively to
evaluate for hydronephrosis and renal function. Of the 506 pa-
tients, 27 (5.3%) met the criteria for silent ureteral stone disease
(global cohort) and underwent DMSA after treatment. Pre- and
postoperative DMSA studies were performed in 9 (34%) of the 27
patients (kidney function cohort). In the other 18 patients, only
postoperative DMSA scans could be obtained. We considered a
difference in kidney relative function of 10% on DMSA per-
formed preoperatively and 90 days after treatment to be abnormal.
Statistical Analysis
Statistical analysis was performed using the Statistical Package
for Social Sciences software program (SPSS, Chicago, IL). The
results are presented as the mean  standard deviation and
range. We used the t test for numeric variables and the chi-
square test or Fisher’s exact test for categorical variables. Two-
tailed P  .05 was considered statistically significant.
RESULTS
Demographic Data
The mean age in the global cohort was 52  15 years
(range 10-80), and most patients were men (n  15;
66%; Table 1). The mean body mass index was 26  4.7
kg/m2 (range 20-35), and almost one half of the patients
(n  13; 48%) had 2 comorbidities, including hyper-
tension in 13, diabetes mellitus in 3, dyslipidemia in 3,
previous cancer in 4, and other diseases in 3. Most had
stones that were left-sided (n 17; 63%) and distal (n
15; 55%), with a mean size of 14  9.3 mm (range 6-45).
The mean preoperative serum creatinine was 0.9  0.26
mg/dL (range 0.43-1.44). The demographic data for the
global and kidney function cohorts are listed in Table 1.
Stones were diagnosed by radiologic abdominal evalua-
tion for nonurologic disease in 11 patients (40%) and by
routine ultrasound examination in 5 (18%). Sixteen pa-
tients were diagnosed with a silent stone due to urologic
disease, and 9 stones (33%) were found during a follow-up
visit after previous nephrolithiasis treatment (Table 2).
Among those, 4 had undergone previous ipsilateral lithiasis
treatment, 2 of whom underwent extracorporeal shock wave
lithotripsy and 2 were treated with open pyelolithotomy.
Hydronephrosis was present in all patients.
Table 1. Demographic data
Variable
Global
Cohort
Kidney Function
Cohort
Patients (n) 27 (100) 9 (34)
Age
Mean  SD 52  15.8 58  12.9
Range 10-80 38-80
Women (%) 44.4 66.7
BMI (kg/m2)
Mean  SD 26  4.7 24  3.3
Range 20-35 20-30
Comorbidities (%)
0 25.93 33.33
1 25.93 22.22
2 48.15 44.44
Diagnostic reason (%)
Nonurologic 40.74 33.33
Urologic 59.26 66.67
Left stone side (%) 63.0 66.7
Stone localization (%)
Proximal 14.81 22.22
Mid 29.63 11.11
Distal 55.56 66.67
Preoperative sCr
(mg/dL)
Mean  SD 0.9  0.26 0.8 0.13
Range 0.43-1.44 0.7-1.1
Stone size (mm)
Mean  SD 14  9.3 12  2.5
Range 6-45 8-15
Hydronephrosis (%)
Mild 18.5 11.1
Moderate 48.1 55.6
Severe 33.3 33.3
SD, standard deviation; BMI, body mass index; sCr, serum creatinine.
Data in parentheses are percentages.
Table 2. Investigative indication for silent ureteral
stone diagnosis
Indication Patients (n)
Nonurologic 11 (40.7)
Routine ultrasonography 5 (18.5)
Intestinal tumor staging 1 (3.7)
Lumbar spine pain 1 (3.7)
Trauma investigation 1 (3.7)
Aortic aneurysm 1 (3.7)
Ultrasound for hepatic disease 1 (3.7)
Systemic lupus erythematosus
investigation
1 (3.7)
Urologic 16 (59.3)
Follow-up after previous nephrolithiasis 9 (33.3)
Renal artery stenosis 2 (7.4)
Prostatic tumor staging 2 (7.4)
Microscopic hematuria 1 (3.7)
Urinary tract infection 1 (3.7)
Pyeloplasty follow-up 1 (3.7)
Data in parentheses are percentages.
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Clinical Outcome
The primary therapy was ureterolithotripsy with laser or
ballistic lithotripters in 24 patients (88%). Of the remaining
3 patients, 2 were treated with ureteroscopy and stone
removal without fragmentation and 1, with a 25-mm prox-
imal ureteral calculus, underwent laparoscopic ureterolitho-
tomy. A stone was considered impacted according to the
intraoperative findings in 19 patients (70%). Double-J cath-
eter insertion after the procedure was required in 23 patients
(90%), and the mean interval to retrieval was 39 26 days
(range 7-100, median 33).
The mean follow-up period was 23  15.4 months
(range 3-54). The overall ureteral stone-free rate after 1
procedure was 96%. One patient required a second pro-
cedure and was successfully treated with laser ureter-
olithotripsy. No urinary tract infections were seen. Two
patients presented to our emergency room because of
double-J catheter-related pain and were successfully
treated with customary analgesics. Ureteral stenosis was
seen in 1 patient during the initial ureteroscopy and in
another patient after stone treatment. Both were success-
fully treated with laser incision and were free of recur-
rence at the last follow-up date.
Kidney Function Outcome
The global cohort’s mean postoperative serum creatinine
was 0.96  0.17 mg/dL (range 0.72-1.42) and did not
differ from preoperative levels (P  .39). The mean
postoperative relative kidney function on DMSA was
31%  20% (range 0%-77%). In 17 patients (63%),
postoperative DMSA revealed impaired renal function
(comparative DMSA difference10%). When analyzing
the effect of stone size on renal function, we found that
11 of the 27 patients had stone size 10 mm (mean
8.1  1.99, range 5-10). In that population, the mean
pre- and postoperative DMSA finding was 20%  13.5%
(range 0%-30%) and 33%  19.2% (range 0%-60%),
respectively. In the 16 patients with calculi 10 mm
(mean 19.1  9.8, range 12-45), the mean pre- and
postoperative DMSA finding was 24%  17.2% (range
0%-49%) and 32%  19.1% (range 0%-77%), respec-
tively. We found no association between stone size and
the pre- or postoperative DMSA findings.
Improvement of hydronephrosis was seen in 19 (70%)
and stabilization in 7 (26%) patients. Only 1 case showed
worsened hydronephrosis (from grade II to grade III). Of
the 9 patients with severe preoperative hydronephrosis, 5
remained unaltered and 4 improved. Of the 4 with im-
provement, 1 had grade II, 1 grade I, and 2 had no
hydronephrosis on the postoperative radiologic examina-
tion. Of the patients with preoperative grade II hydrone-
phrosis, 1 worsened to grade III, 1 remained at grade II,
and 11 improved (3 to grade I and 8 to no hydronephro-
sis). Finally, of the patients with mild preoperative hy-
dronephrosis, 1 stayed at the same grade and 4 showed
complete resolution. We found no association between
stone size and postoperative hydronephrosis resolution.
Preoperatively, all 9 patients in the kidney function
cohort presented with impaired renal function and a
mean DMSA of 22%  12.1% (range 0%-38%). The
mean preoperative serum creatinine was 0.8  0.13
mg/dL (range 0.7-1.1; Table 3). Of the 3 patients who
presented with severe hydronephrosis preoperatively, 1
remained unchanged and 2 improved. Five patients pre-
sented with moderate hydronephrosis (grade II) preoper-
atively. Of these 5, 1 worsened and 4 had complete
resolution. The only patient with mild hydronephrosis
showed resolution after stone removal. Postoperatively,
the mean DMSA was 20%  11.8% (range 0%-30%),
and the mean serum creatinine was 1.0  0.21 mg/dL
(range 0.7-1.4). No difference was seen between the pre-
and postoperative DMSA findings (P  .83) and creat-
inine levels (P  .45; (Table 3).
COMMENT
The number of patients seeking urologic counseling because
of the incidental finding of an asymptomatic kidney stone is
increasing.1 Management algorithms have been established
for both symptomatic and silent kidney stones based on
research of the natural history of nephrolithiasis.6,7 In con-
trast, quiet ureteral calculi disease and its potential burden
have been poorly studied. Our report is the first to study the
influence of stone removal on the recovery of renal function
using pre- and postoperative DMSA analysis in this popu-
lation. For the most part, studies published on the topic of
asymptomatic ureteral calculi have been case series investi-
gating the natural history of ureterolithiasis or revisions for
post-treatment follow-up.7,9,10
Weizer et al10 retrospectively reviewed the data from
241 patients who had undergone endoscopic procedures
for ureteral/renal calculi and found postoperative obstruc-
tion due to residual stone fragments in 30 patients. Of
these 30 patients, 7 (2.9% of the total cohort) presented
with silent obstruction, and 1 of these patients developed
renal failure requiring dialysis. This group emphasized the
importance of routine postoperative imaging, and they
were the first to report a case of complete kidney function
loss because of a silent ureteral stone. Wimpissinger et al8
were the first to prospectively investigate the natural
history of silent ureteral stones. In a 12-year period, they
found that of 3711 patients diagnosed with a ureteral
stone requiring surgical or medical intervention, 1.1%
had silent ureteral calculi disease. Only 22.5% of the 40
patients had pre-existing nephrolithiasis disease. Silent
disease was found based on the incidental diagnosis of
hydronephrosis in 10 patients, the finding of microscopic
hematuria in 8 patients, and on nonurologic radiographic
examinations in 13 patients. The percentage of silent
disease reported in their study was lower than reported in
ours, probably because they included patients treated
clinically. In our series, silent calculi disease represented
5.3% of all patients needing intervention. Undoubtedly,
our study had a selection bias because all our patients
were referred for urologic evaluation. We did not include
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patients with an incidentally discovered ureteral stone
who were not referred to a urologist or those with a
stone not requiring surgery, simply because we did not
have access to that population. In contrast, those patients
are probably at the best end of the disease spectrum and
might have better outcomes than our cohort. With re-
gard to diagnostic modality, our numbers were similar,
with 33% of stones found after previous nephrolithiasis
treatment. In their series, most patients (65%) had at
least some grade of hydronephrosis, and the mean creat-
inine level was 1.1 mg/dL (range 0.8-2.4). Only 1 patient
had spontaneous passage of the stone before treatment.
Extracorporeal shock wave lithotripsy was performed in
87.5% of their patients. Auxiliary ureteroscopy or extra-
corporeal shock wave lithotripsy was required in 30% of
patients, and the final stone-free rate was 90%. In con-
trast, our main treatment modality was ureteroscopy with
laser fragmentation, and our stone-free rate was higher
(96% after 1 procedure) with fewer auxiliary interven-
tions. Ultrasonography was the follow-up imaging modal-
ity for most of our patients. In contrast to our series,
pyelography was not routinely performed for all patients.
Furthermore, we only included patients with some degree
of hydronephrosis. Collecting system dilation can pre-
cede and predispose to stone formation, as well as be
secondary to silent calculi obstruction. In general, such
discrimination is not possible. Our double-J stenting time
was long, mainly because most patients presented with an
impacted ureteral stone. One patient missed the postop-
erative visits and had her stent removed only 3 months
after surgery. Also, we had a tendency to leave the stents
in place longer than we would for symptomatic cases
because the sequence of local events after silent ureteral
stone removal remains unclear.
Few publications have address the effect of ureteral
stones on kidney function, and most studies have con-
sidered symptomatic disease. Mahmoud et al9 reported a
case of silent distal ureteral obstruction seen on a fol-
low-up pyelogram 6 weeks after extracorporeal shock
wave lithotripsy. Kidney function was decreased at diag-
nosis and did not change after stone removal. Andrén-
Sandeberg et al11 prospectively followed up 358 patients
with ureteral stones until the calculus was spontaneously
eliminated, and they found renal function impairment in
25%. Intervention was required in 27% of patients with-
out any symptoms. Persistent decreased renal function on
pyelography was seen in 7% of patients and was mostly
mild. Kelleher et al12 studied 76 patients with radio-
graphically proven acute calculous obstruction and found
that stones 5 mm were more likely to cause an obstruc-
tion and decrease the relative renal function and, there-
fore, demand intervention. Decreased renal function was
found in 18% of patients, but only 2 patients who had
had previous treatment for a calculus had persistent kid-
ney impairment after stone removal. Finally, Irving et
al13 prospectively followed up 54 patients with ureteral
calculi 4 mm and found that 28% of patients had silentT
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loss of renal function, obligating treatment at diagnosis.
For this particular group, they also studied the effect of
treatment timing on the recovery of renal function, with
better results when the intervention took place within
the first week. The same significant relationship was not
found for patients with stones causing diminished func-
tion when a coexisting infection was present, suggesting
the infection itself might cause additional cellular dam-
age and direct parenchymal impairment. In our series, all
patients had stones 5 mm and the interval from stone
impaction to removal could not be obtained, because it is
impossible to determine the exact time of calculi migra-
tion toward the ureter owing to the lack of symptoms.
We found no relationship between stone size and renal
function on DMSA. In our global cohort, a creatinine
level greater than the normal limit (1.2 ng/dL) was
seen in only 1 patient preoperatively and in 2 postoper-
atively. Although hydronephrosis improved or stabilized
in almost all patients (96%), the postoperative ipsilateral
DMSA revealed impaired renal function in most patients
(63%). Renal lesions caused by chronic calculi obstruc-
tion were evident. If we had decided to simply observe
our patients, it is likely we would have seen a progressive
deterioration in renal function. Therefore, such a prac-
tice seems illogical and unethical.
Although small in size, the demographic data of our
kidney function cohort were very similar to those of our
global cohort. Our findings for the global cohort were
corroborated by preoperative DMSA pyelograms ob-
tained for 9 of the patients studied. At diagnosis, all had
significant renal function impairment, although the cre-
atinine levels were normal. Comparative pre- and post-
operative DMSA analyses showed no worsening of renal
function. Although lesions of nephrons could not be
prevented or reversed, stone treatment stabilized the rel-
ative kidney function, and immediate treatment after
diagnosis seems imperative. We only considered patients
with hydronephrosis, and we cannot speculate whether
the same treatment is suitable for patients with an asymp-
tomatic ureteral stone without collecting system dilation.
We advocate DMSA pyelography for all patients with a
silent ureteral stone, even for those without any degree of
hydronephrosis. The observation of patients without
DMSA-altered results cannot be advocated. However, if
relative renal function is decreased, immediate calculi
treatment is mandatory to avoid additional kidney func-
tion impairment. In our series, the attempt to improve
renal function in patients with preoperative DMSA find-
ings 5% failed. We consider observation of those pa-
tients or laparoscopic simple nephrectomy if any compli-
cation develops. One could raise the question of whether
we should be more invasive and surgically treat all pa-
tients with silent ureteral stone disease, regardless of
whether hydronephrosis is present, to prevent potential
renal injury. We cannot answer that question from the
findings from our series because we did not include such
a cohort. A prospective randomized trial comparing the
pre- and postoperative DMSA studies of patients treated
with silent stone removal in the absence of hydronephro-
sis seems feasible and will be performed in our depart-
ment. Our institution plays an important role in the
healthcare for a particular low socioeconomic population
in Brazil. This fact might influence the imaging modality
and motive for radiologic investigation at incidental find-
ings of calculi. Moreover, those individuals tend to un-
derestimate the disease burden, because it is foremost an
asymptomatic abnormality. Finally, difficulty in health-
care access could lengthen the time from diagnosis to
treatment and worsen the disease prognosis.
CONCLUSIONS
Silent ureteral stones causing hydronephrosis are associ-
ated with decreased kidney function present at diagnosis.
Although hydronephrosis tends to diminish or resolve
after stone removal, renal function is likely to remain
unchanged. The treatment of a silent ureteral stone at
diagnosis might slow or stop continuous renal scarring
and preserve kidney function.
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